In October 2025, Genentech, in collaboration with Natera, announced positive phase 3 IMvigor011 trial results showing that the Signatera test improved disease-free and overall survival in ...

Q3 2025 Earnings Call Transcript October 27, 2025 BioMarin Pharmaceutical Inc. misses on earnings expectations. Reported EPS ...

Palantir’s (PLTR) hot streak just got a brand new tailwind. The stock has been a standout performer this year, surging to new ...

Discover eight key AI biotech deals that have been made so far in 2025, spotlighting where industry leaders are betting big.

An African state-owned diamond company has submitted a formal offer to buy South African diamond mining giant De Beers.

Thank you, Jenny, and good morning, everyone. Welcome to the NeoGenomics Third Quarter 2025 Financial Results Call. With me today to discuss the results are Tony Zook, Chief Executive Officer; and ...

Happy Wednesday! Amazon is likely to lay off hundreds in India as part of its global job cuts. This and more in today's ...

The Gujarat government has just given the green light that could redefine Dholera’s skyline. GAP Group’s flagship township, Akhilam, has received environmental ...

Discover why ANIP may beat earnings estimates again, expand with new drug approvals, and raise 2025 guidance. Click here to ...

Q3 2025 net product revenue of $180.9 million, representing 61% year-over-year growth –– ARCALYST 2025 expected net ...

The Arkansas lithium gamble is increasingly being framed as essential to countering China's dominance in renewables, minerals ...